CSIR
-
Anti-COVID drug ‘Colchicine’ cleared for phase 2 clinical trials
New Delhi: Council of Scientific & Industrial Research (CSIR), and Laxai Life Sciences Pvt. Ltd., Hyderabad, have been given the…
Read More » -
Pact signed to manufacture anti-COVID drug 2-DG
New Delhi: CSIR-Indian Institute of Chemical Technology Hyderabad, a constituent laboratory of Council of Scientific and Industrial Research (CSIR) and Anthem…
Read More » -
New drug for coronary diseases could be in offing
New Delhi: Council of Scientific and Industrial Research (CSIR)’s Lucknow-based constituent laboratory Central Drug Research Institute (CDRI) and Marc Laboratories…
Read More » -
GIS-based mapping of microbial diversity of river Ganga
New Delhi: Council of Scientific & Industrial Research (CSIR)’s Nagpur based constituent laboratory National Environmental Engineering Research Institute (NEERI), has…
Read More » -
Good news amidst the nationwide Oxygen shortage
New Delhi: The nation is reeling under an unprecedented wave of COVID-19 infections. India’s number of COVID infections reported in…
Read More » -
CSIR-CMERI transfers COVID related technologies for commercial production
New Delhi: Along with scientific and technology-based innovations, their commercial production is equally important. In a recent initiative, CSIR-Central Mechanical…
Read More » -
Raw drug repository for medicinal herbs established in CSIR-NBRI
New Delhi: The National Botanical Research Institute (NBRI), a Lucknow-based constituent laboratory of the Council of Scientific and Industrial Research…
Read More »